Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and Perspectives
Metabolism of tryptophan (Trp), an essential amino acid, represent a major metabolic pathway that both promotes tumor cell intrinsic malignant properties as well as restricts antitumour immunity, thus emerging as a drug development target for cancer immunotherapy. Three cytosolic enzymes, namely ind...
Main Authors: | Florent Peyraud, Jean-Philippe Guegan, Dominique Bodet, Sophie Cousin, Alban Bessede, Antoine Italiano |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.807271/full |
Similar Items
-
Biological and clinical significance of tryptophan-catabolizing enzymes in cutaneous T-cell lymphomas
by: Pilvi Maliniemi, et al.
Published: (2017-03-01) -
Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy
by: Concetta Elisa Onesti, et al.
Published: (2019-07-01) -
TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
by: V. A. Kozlov, et al.
Published: (2017-07-01) -
Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1
by: Andrea Botticelli, et al.
Published: (2020-07-01) -
The Relationships among Tryptophan, Kynurenine, Indoleamine 2,3-Dioxygenase, Depression, and Neuropsychological Performance
by: Knut A. Hestad, et al.
Published: (2017-10-01)